IBD
Just Say No to Paying Cybersecurity Ransom
Health systems and other sites of care should never pay a ransom demand from a cyberattacker, even if that seems to ...
MARCH 20, 2025
Malnutrition Is Endemic to IBD, but Can Be Managed
Correcting the harms of malnutrition in inflammatory bowel disease often leads to better response to biologic ...
JULY 27, 2024
Postoperative Considerations in IBD
This month, we look at two examples of how to manage postoperative inflammatory bowel disease.
MARCH 25, 2024
Advanced Therapies for IBD Do Not Appear To Raise Thrombotic Risk
In patients with IBD, neither biologics nor small molecule targeted therapies increase the risk for major adverse ...
JANUARY 1, 2024
Embedded Clinical Pharmacist a Champion for IBD Care
When the COVID-19 pandemic hit in early 2020, 50-year-old Regina Paritsky, MEd, BCBA, found a silver lining in the ...
OCTOBER 27, 2023
FDA Approves Zymfentra for IBD
The FDA approved Zymfentra for the treatment of inflammatory bowel disease.
OCTOBER 27, 2023
Using Data-Driven Monitoring Tools Boosts SP Outcomes
Vanderbilt Specialty Pharmacy has harnessed the power of patient monitoring tools to manage IBD, asthma and other ...
OCTOBER 13, 2023
In UC, Tofacitinib and Ustekinumab Perform Similarly After Biologic Failure
In biologic-experienced patients with ulcerative colitis, tofacitinib and ustekinumab achieve about the same rate ...
MAY 17, 2023
Racial Disparities Seen in Use of IBD Medical Therapy
Black patients with IBD are less likely to be treated with certain therapies than white IBD patients, according to ...
JANUARY 17, 2023
Older-Onset IBD Linked to Antibiotic Use
Antibiotic use in people 60 years of age and older is associated with IBD development, according to a new study ...
MAY 24, 2022
Mortality Rates Higher in Opioid-Dependent IBD Patients
Hospitalized inflammatory bowel disease patients with opioid dependence have a threefold risk for in-hospital ...
MAY 19, 2022
IBD Drugs Don’t Raise the Risk For Cancer Progression, Recurrence
Treatment with biologics and immunosuppressants does not increase the risk for cancer progression or recurrence in ...
MAY 5, 2022
